RecruitingNCT06840288

Bronchoscopic Lung Ablation of Small Thoracic Tumors: the Blastt Registry


Sponsor

M.D. Anderson Cancer Center

Enrollment

250 participants

Start Date

Feb 19, 2025

Study Type

OBSERVATIONAL

Conditions

Summary

To aggregate, integrate, and analyze data facilitating the study of MD Anderson patients with a known diagnosis of lung cancer or metastases to the lungs who undergo robotic assisted bronchoscopic ablation of peripheral tumors.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting data on patients who have a lung tumor treated using robotic bronchoscopy-guided ablation — a minimally invasive procedure where a thin tube is guided through the airways to reach and destroy small lung tumors using heat, cold, or microwave energy. Unlike surgery, no chest incisions are needed. The study tracks outcomes over time to better understand the safety and effectiveness of this approach in real-world patients with primary or metastatic lung tumors. **You may be eligible if...** - You have a small peripheral lung tumor (either a primary lung tumor or a metastasis that has spread from another cancer) - Your tumor has been treated or is planned to be treated with robotic bronchoscopy-guided ablation - Your doctor can safely complete the ablation procedure in full **You may NOT be eligible if...** - Your planned ablation procedure was started but could not be completed for technical reasons (the ablation was aborted before finishing) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

MD Anderson Cancer Center

Houston, Texas, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06840288


Related Trials